Adapt Pharma’s Nasal Spray Uses Unit-Dose Delivery System

Single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.

Single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.
Single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.

Last November, the U.S. FDA approved Radnor, PA-based Adapt Pharma’s NARCAN® (naloxone hydrochloride) nasal spray for the emergency treatment of known or suspected opioid overdose.

Aptar Pharma recently announced that it provided the delivery system and regulatory support for Narcan, which it referred to as “the first U.S. FDA-approved nasally administered, needle-free, ready-to use medication that can stop or reverse the effects of an opioid overdose.”

The liquid spray drug delivery technology platform provides dose accuracy and ease of administration. The single-shot unit-dose system incorporates a primeless feature and 360-degree orientation to offer the patient or caregiver ready-to-use convenience.

Annual Outlook Report: Sustainability
The road ahead for CPGs in 2025 and beyond—Packaging World editors review key findings from a survey of 88 brand owners, CPG, and FMCG readers.
Download Now
Annual Outlook Report: Sustainability
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report